Brain CommunicationsNeurosciencePeer-reviewed journal article
Distinctive alteration of presynaptic proteins in the outer molecular layer of the dentate gyrus in Alzheimer's disease
Hazal HayturaliD, Tomás Jordá-SiquieriD, Bengt G. WinbladiD, Christophe MulleiD, Lars O. TjernbergiD, Ann‐Charlotte GranholmiD, Susanne FrykmaniD, Gaël BarthetiD
Abstract
Synaptic degeneration has been reported as one of the best pathological correlate of cognitive deficit in Alzheimers Disease (AD). However, the location of these synaptic alterations within hippocampal sub-regions, the vulnerability of the presynaptic versus postsynaptic compartments, and the biological mechanisms for these impairments remain unknown. Here, we performed immunofluorescence labeling of different synaptic proteins in fixed and paraffin embedded human hippocampal sections and report reduced levels of several presynaptic proteins of the neurotransmitter release machinery (complexin-1, syntaxin-1A, synaptotagmin-1 and synaptogyrin-1) in AD cases. The deficit was restricted to the outer molecular layer (OML) of the dentate gyrus whereas other hippocampal sub-fields were preserved. Interestingly, standard markers of postsynaptic densities (SHANK2) and dendrites (MAP2) were unaltered, as well as the relative number of granule cells in the dentate gyrus, indicating that the deficit is preferentially presynaptic. Notably, staining for the axonal components, myelin basic protein, SMI-312 and Tau, was unaffected, suggesting that the local presynaptic impairment does not result from axonal loss or alterations of structural proteins of axons. There was no correlation between the reduction in presynaptic proteins in OML and the extent of the amyloid load or of the dystrophic neurites expressing phosphorylated forms of Tau. Altogether, this study highlights the distinctive vulnerability of the OML of dentate gyrus and supports the notion of presynaptic failure in AD.
- Citations
- 24
- FWCI
- 1.42
- Field percentile
- top 21%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A synaptic-astrocytic proteomic signature associated with synaptopathy in Alzheimer's Disease
Jessica Griffiths, Eléonore Schneegans, … Johanna Jackson·bioRxiv·Jan 23, 2025
- Stage-specific proteomic signatures of synaptopathy in Alzheimers disease
Tatiana Georgiades, Jessica Griffiths, … Johanna Jackson·bioRxiv·Oct 8, 2026
- Single-synapse analyses of Alzheimers disease implicate pathologic tau, DJ1, CD47, and ApoE
Thanaphong Phongpreecha, Chandresh R. Gajera, … Thomas Jude Montine·Science AdvancesPeer-reviewed·Dec 15, 2021
- 3D analysis of the synaptic organization in the Entorhinal cortex in Alzheimer's disease
Marta Domínguez-Álvaro, Marta Montero‐Crespo, … Lidia Alonso‐Nanclares·eNeuroPeer-reviewed·May 1, 2021
- Comparative profiling of the synaptic proteome from Alzheimer’s disease patients with focus on the APOE genotype
Raphael Hesse, Maica Llavero Hurtado, … Tara L. Spires‐Jones·Acta Neuropathologica CommunicationsPeer-reviewed·Dec 1, 2019
- Tau oligomers modulate synapse fate by eliciting progressive bipartite synapse dysregulation and synapse loss
Kristeen A. Pareja-Navarro, Christina D. King, … Tara E. Tracy·Molecular NeurodegenerationPeer-reviewed·Jan 22, 2026